BioSpace News Archive

Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that members of the management team will present at the virtual Chardan Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 25, 2022, at 9:30 AM ET.

ARCA biopharma, Inc. today announced that its Board of Directors has established a Special Committee to evaluate strategic options for maximizing stockholder value.

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its first quarter 2022 financial results after market close on Monday, May 9, 2022.

Olema Pharmaceuticals, Inc. today announced that the Company granted a stock option to one new employee to purchase 20,000 shares of the Company’s common stock, effective as of April 1, 2022.

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of an inducement award to one new employee.

Repro Med Systems, Inc. today announced the appointment of Brian Case, a veteran medical technology R&D leader with over 20 years of experience, as the Company’s new Chief Technology Officer.

Retractable Technologies, Inc. (NYSE American: RVP) reports that, effective April 14, 2022, it has terminated its Rule 10b5-1/10b-18 Repurchase Plan dated June 4, 2021.

TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company that specializes in disinfection and decontamination through the utilization of its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, published a letter from the Company’s Chief Executive Officer, Dr. Halden Shane, to shareholders.

EDDA Technology announced today it has entered into an agreement with the Society of Interventional Oncology (SIO) for their ACCLAIM Trial.

The American Society for Preventive Cardiology (ASPC) announces the official program for the ASPC 2022 Congress on CVD Prevention, scheduled July 29-31, 2022 in Louisville, KY.